Evidence map›Paper›PMID 31302638›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020

Lymph Node Involvement in Treatment-Naïve Prostate Cancer Patients: Correlation of PSMA PET/CT Imaging and Roach Formula in 280 Men in Radiotherapeutic Management.

Stefan A Koerber, Gerald Stach, Clemens Kratochwil, Matthias F Haefner, Henrik Rathke, Klaus Herfarth, Klaus Kopka, Tim Holland-Letz, Peter L Choyke, Uwe Haberkorn and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Automated segmentation of lesions and organs at risk on [Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Article
  6. Article
  7. Polish journal of radiology · 2023
    Article
  8. Review
  9. PSMA PET in Imaging Prostate Cancer.Frontiers in oncology · 2022
    Review
  10. Head-to-Head Comparison ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer.European journal of nuclear medicine and molecular imaging · 2021
    Article
  17. The Roach Equation: Value of Old Clinical Tools in the Era of New Molecular Imaging.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Article
  18. Interobserver agreement of [EJNMMI research · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Stefan A KoerberDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Gerald StachDepartment of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Clemens KratochwilDepartment of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Matthias F HaefnerDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Henrik RathkeDepartment of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Klaus HerfarthDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Klaus KopkaDivision of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg, Germany.
Tim Holland-LetzDepartment of Biostatistics, German Cancer Research Center, Heidelberg, Germany.
Peter L ChoykeMolecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and.
Uwe HaberkornDepartment of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Juergen DebusDepartment of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Frederik L GieselDepartment of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany frederik.giesel@med.uni-heidelberg.de.
University Hospital Heidelberg · DEDeutschen Konsortium für Translationale Krebsforschung · DEGerman Cancer Research Center · DEHeidelberg University · DENational Cancer Institute · USNational Center for Tumor Diseases · DE

Funding

Lymphatic ImagingZIABC010654 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2020
$4.8M
6 · The paper itself

Abstract

The importance of prostate-specific membrane antigen (PSMA) PET/CT for primary staging of treatment-naïve prostate cancer patients is still under debate. Therefore, the present study aimed to evaluate the role of PSMA PET/CT in detecting nodal metastases in a large cohort of men and compare imaging results with the risk of lymph node involvement based on the Roach formula.

Indexed as

AdultAgedAged, 80 and overAlgorithmsAntigens, SurfaceArea Under CurveCarcinomaGlutamate Carboxypeptidase IIHumansLymphatic MetastasisLymph NodesMaleMiddle AgedPositron Emission Tomography Computed TomographyProstateProstatic NeoplasmsAntigens, SurfaceFOLH1 protein, humanGlutamate Carboxypeptidase IIPET/CTprostate cancerPSMARoach formulaVirchow

Identifiers

PMID31302638
PMCPMC6954455
OpenAlexW2958551102

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.